top of page

Health Care Professionals

A dedicated hub for clinicians, researchers, and healthcare leaders evaluating ibogaine’s role in modern medicine and its integration into professional clinical frameworks.

Latest Medical Research

Explore curated clinical insights and peer-reviewed data evaluating the efficacy and safety of ibogaine in medical contexts. For deeper analysis, visit our partner Psychedelic Alpha.

Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture.

​

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond.

Clinical Safety Overview (WebMD)

This external page provides a general overview of iboga’s safety profile and medical context, offering critical clinical guidance and medical assessment data for healthcare professionals and researchers. Access Full WebMD Resource Overview

The OPEN Foundation views psychedelic-assisted therapy as a transformative approach that complements existing treatments. While the evidence is growing and provides "cautious optimism," the page concludes that more research and standardized clinical protocols are necessary before these therapies can be fully integrated into mainstream healthcare.

Strategic Partnerships & Clinical Collaboration

We invite hospitals, specialized clinics, and clinical researchers to explore strategic collaboration. Join us in shaping the standards for ibogaine-assisted healthcare delivery and economic integration.

bottom of page